Home > Insider Trading > Filing (0001562180-22-001105)

Filing Details

Accession Number:: 0001562180-22-001105
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-03 21:30:55
Reporting Period:: 2022-01-31

Accepted Time:: 2022-02-03 21:30:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1603756	Axonics Inc.	AXNX	Surgical & Medical Instruments & Apparatus (3841)	454744083

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1756438	L. Danny Dearen	26 Technology Drive Irvine CA 92618	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-01	20,000	$14.19	30,000	No	4	M	Direct
Common Stock	Disposition	2022-02-01	2,017	$46.83	27,983	No	4	S	Direct
Common Stock	Disposition	2022-02-01	3,730	$48.26	24,253	No	4	S	Direct
Common Stock	Disposition	2022-02-01	13,853	$49.07	10,400	No	4	S	Direct
Common Stock	Disposition	2022-02-01	400	$49.70	10,000	No	4	S	Direct
Common Stock	Acquisiton	2022-01-31	11,000	$0.00	21,000	No	4	A	Direct
Common Stock	Acquisiton	2022-02-03	36,919	$0.00	46,919	No	4	M	Direct
Common Stock	Disposition	2022-02-03	17,737	$48.21	29,182	No	4	S	Direct
Common Stock	Disposition	2022-02-03	947	$49.03	28,235	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-02-01	20,000	$0.00	20,000	$14.19
Common Stock	Performance-Based Restricted Stock Units	Acquisiton	2022-01-31	5,250	$0.00	5,250	$0.00
Common Stock	Performance-Based Restricted Stock Units	Acquisiton	2022-01-31	5,250	$0.00	5,250	$0.00
Common Stock	Performance-Based Restricted Stock Units	Disposition	2022-02-03	10,833	$0.00	10,833	$0.00
Common Stock	Performance-Based Restricted Stock Units	Disposition	2022-02-03	26,086	$0.00	26,086	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,468		2029-01-30	No	4	M	Direct
5,250	2023-01-31		No	4	A	Direct
5,250	2024-01-31		No	4	A	Direct
0	2022-01-31		No	4	M	Direct
0	2021-12-31		No	4	M	Direct

Footnotes

The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023.
The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024.
Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022.
The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021.
This transaction was executed in multiple trades at prices ranging from $46.475 to $47.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $47.66 to $48.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $48.66 to $49.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $49.66 to $49.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein.
This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.